PMC:7558914 / 25085-25242
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T39 | 27-34 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T40 | 27-34 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 607 | 27-34 | Chemical | denotes | heparin | MESH:D006493 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T160 | 0-157 | Sentence | denotes | In five protocols (33.3%), heparin was increased to therapeutic doses if the condition was critical or if there was a progressive increase in D-dimer levels. |